




Searching News Database: Renvela
HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
HSMN NewsFeed - 20 Dec 2017
Amneal Brings Generic for Renvela(R) to Market and Starts December Strong with Six Product Launches
Amneal Brings Generic for Renvela(R) to Market and Starts December Strong with Six Product Launches
HSMN NewsFeed - 21 Jan 2014
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
HSMN NewsFeed - 4 Mar 2013
Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer
Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer
HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
HSMN NewsFeed - 21 Dec 2006
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis